Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

6,218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells.
Zhu GQ, Tang Z, Chu TH, Wang B, Chen SP, Tao CY, Cai JL, Yang R, Qu WF, Wang Y, Zhao QF, Huang R, Tian MX, Fang Y, Gao J, Wu XL, Zhou J, Liu WR, Dai Z, Shi YH, Fan J. Zhu GQ, et al. Among authors: dai z. Signal Transduct Target Ther. 2025 Jan 22;10(1):25. doi: 10.1038/s41392-024-02118-2. Signal Transduct Target Ther. 2025. PMID: 39837814 Free article.
6,218 results